Clinical trials
Chronic kidney disease clinical trials
A gradual loss of kidney function over time. We’re tracking 559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07642778Recruiting
Measuring Leg Strength in Kidney Disease Patients on Dialysis
This study measures how strong your leg muscles are in patients with chronic kidney disease who receive dialysis treatment. Understanding normal strength patterns may help doctors better support kidney disease patients' physical health and quality of life.
MadridAges 18–85 - NCT07613593Recruiting
Digital kidney disease care platform evaluation study
This study evaluates whether MyRenalCare, a digital platform that helps patients with chronic kidney disease (CKD) monitor and manage their condition, improves health outcomes and patient experience. Researchers will compare people using the platform with those receiving standard care, and interview patients and staff about their experiences.
Portsmouth, HampshireAges 18 years+ - NCT07678073Recruiting
Comparing Anesthesia Types for Kidney Transplants
This study compares two types of anesthesia (general gas anesthesia vs. a spinal-plus-epidural method) during living-donor kidney transplants to see how they affect certain body signals related to cell health and aging. If you are having a kidney transplant from a living donor and are in good overall health, this trial could help doctors learn which anesthesia may be better for you.
Gaziantep, State/ProvinceAges 18–70 - NCT07710183Recruiting
Pumpkin seed oil for hemodialysis patients
This study tests if pumpkin seed oil, a natural supplement, can improve health in people on long-term dialysis. It may help with inflammation and nutrition without using prescription drugs.
Baghdad, KarkhAges 18 years+ - NCT07746102Recruiting
Preconditioning therapy for chronic kidney disease patients
This study tests whether repeated brief periods of reduced blood flow (like a gentle squeeze on your arm) can improve how your body handles energy and blood flow. It is designed for people with any stage of chronic kidney disease (G1–G5).
LodzAges 18 years+ - NCT07748858Recruiting
Heart care support for older African American patients
This study aims to improve care for older African American patients with heart conditions and other health problems. It tests ways to provide more patient-centered support.
Birmingham, AlabamaAges 50–99 - NCT07820514Recruiting
Exercise during dialysis for kidney disease
This trial tests whether a structured exercise program during dialysis sessions can help people with chronic kidney disease feel better and improve their health. It is designed for patients who are stable on dialysis and may offer a way to enhance well-being during treatment.
Torre del GrecoAges 18 years+ - NCT07673822Enrolling by invitation
Heart, kidney, and metabolic disease study in Korea
This study looks at how common heart, kidney, and metabolic problems are in Korea by using health insurance records. It will help doctors understand how often these conditions happen together.
SeoulAges 19 years+ - NCT07662889Enrolling by invitation
Comparing two types of dialysis for kidney failure
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
Lahore, Punjab ProvinceAges 18–70 - NCT07645794Enrolling by invitation
MRI Scans to Detect Bone and Muscle Loss in Kidney Disease
This study tests a new MRI imaging method to detect bone loss (osteoporosis) and muscle loss (sarcopenia) in people with chronic kidney disease. The scan may help doctors catch these problems earlier and manage kidney disease better.
Beijing, Beijing MunicipalityAges 18–80 - NCT07541495Enrolling by invitation
Mindfulness Training for Adults With Chronic Kidney Disease
This study tests whether a mindfulness program (guided meditation and breathing exercises delivered on a smartphone) can help people manage chronic kidney disease and improve their quality of life. You'll use a study-provided app to practice mindfulness several times a week for 8 weeks.
New Haven, ConnecticutAges 18–80 - NCT07355296RecruitingPhase 2
Testing BI 764198 in adults and teens with kidney disease
This study tests an investigational drug (BI 764198) in adults and teens with different types of kidney disease. The goal is to see if the drug can help slow kidney damage. You may be able to join if your kidney function is at a certain level, you are on stable blood pressure medications, and you haven't had recent strong immune treatments.
Huntsville, AlabamaAges 12 years+ - NCT07271186RecruitingPhase 2
Study of an experimental drug for kidney disease from type 2 diabetes
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Huntsville, AlabamaAges 18–80 - NCT07245186Enrolling by invitation
Healthy living program for kidney decline
This study tests a program to help people with chronic kidney disease (CKD) stay healthy through diet tracking and other proactive steps. It focuses on people whose kidney function has declined but who are not yet on dialysis.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT07141043Recruiting
Bone health study after kidney transplant
This study looks at bone and mineral disorders in people on dialysis, after a kidney transplant, or with bone thinning. It aims to understand how these conditions affect bone health.
IașiAges 20–70 - NCT07045467RecruitingPhase 1
Remimazolam for sedation during kidney transplant
This study tests whether a sedative called remimazolam works well and safely for people getting a kidney transplant. It might help you stay calm and comfortable during surgery.
Jinan, ShangdongAges 18–65 - NCT06830629RecruitingPhase 2
MZE829 for APOL1 kidney disease
This trial tests an experimental drug called MZE829 for people with kidney disease linked to the APOL1 gene. It aims to see if the drug can help protect kidney function.
Decatur, AlabamaAges 18–68 - NCT06325644Recruiting
Ketogenic diet for polycystic kidney disease
This study tests whether a ketogenic diet can slow the progression of polycystic kidney disease in adults who are at risk for rapid decline. You'll follow a carefully planned low-carb, high-fat diet to see if it helps protect your kidneys.
Columbus, OhioAges 18–65 - NCT06217302RecruitingPhase 3
Sotagliflozin for kidney protection in type 1 diabetes
This study tests whether sotagliflozin (a pill that helps control blood sugar and protects the kidneys) can slow down kidney function decline in people with type 1 diabetes and diabetic kidney disease. You may qualify if you have had type 1 diabetes for at least 8 years, have moderate kidney damage, and are on standard treatments.
Stanford, CaliforniaAges 18–75 - NCT03716401Recruiting
Imaging tests to predict kidney disease in type 2 diabetes
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
TurkuAges 18–80 - NCT03569735Recruiting
Elderly health survey in Nanshan, Shenzhen
This study follows people age 65 and older in Nanshan to learn about health over time using surveys and health samples. It may help researchers understand what supports healthy aging in the community.
Shenzhen, GuangdongAges 65 years+ - NCT03595267Recruiting
Kidney health checks and care for Indigenous communities
This study offers kidney-related health screening and follow-up care for people in Indigenous communities. It’s designed to help check kidney health early using simple health measurements, and may help you get guidance sooner if anything looks off.
Calgary, AlbertaAges 10–80 - NCT06396416RecruitingPhase 4
Obesity management after kidney transplant
This study tests whether a weight loss medication (semaglutide) can help manage obesity in people who have had a kidney transplant or are at high risk. It aims to improve health outcomes and prevent further kidney decline.
London, OntarioAges 18 years+ - NCT05726526Recruiting
Phone app monitoring to help people with advanced kidney disease
This study tests a phone app (with check-ins on things like blood pressure and weight) to help prevent complications in people with advanced chronic kidney disease. You may be a good match if you’re high risk and can actively measure and share your health data with a kidney care team.
Winnipeg, ManitobaAges 18 years+
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chronic kidney disease?
- Yes. Clin2 currently lists 559 recruiting chronic kidney disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chronic kidney disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chronic kidney disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.